FALSINI, MATTEO
 Distribuzione geografica
Continente #
NA - Nord America 2.249
EU - Europa 1.165
AS - Asia 922
SA - Sud America 102
AF - Africa 22
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 4
Totale 4.476
Nazione #
US - Stati Uniti d'America 2.215
RU - Federazione Russa 408
IT - Italia 267
SG - Singapore 229
CN - Cina 225
HK - Hong Kong 148
IE - Irlanda 128
VN - Vietnam 127
PL - Polonia 105
SE - Svezia 89
BR - Brasile 79
KR - Corea 58
IN - India 46
FR - Francia 34
DE - Germania 32
GB - Regno Unito 30
FI - Finlandia 24
JO - Giordania 23
CA - Canada 20
ES - Italia 20
JP - Giappone 14
AR - Argentina 12
AU - Australia 11
ID - Indonesia 11
NL - Olanda 11
BD - Bangladesh 10
MX - Messico 10
TR - Turchia 7
IQ - Iraq 6
UA - Ucraina 6
BE - Belgio 4
EG - Egitto 4
EU - Europa 4
PK - Pakistan 4
SN - Senegal 4
CI - Costa d'Avorio 3
MA - Marocco 3
PE - Perù 3
ZA - Sudafrica 3
AZ - Azerbaigian 2
EC - Ecuador 2
MY - Malesia 2
OM - Oman 2
PY - Paraguay 2
TN - Tunisia 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AO - Angola 1
AW - Aruba 1
BY - Bielorussia 1
BZ - Belize 1
CH - Svizzera 1
CL - Cile 1
CO - Colombia 1
CR - Costa Rica 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
JM - Giamaica 1
KE - Kenya 1
LB - Libano 1
LT - Lituania 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PH - Filippine 1
RO - Romania 1
SA - Arabia Saudita 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 4.476
Città #
Santa Clara 567
Ashburn 314
Fairfield 149
Chandler 141
Singapore 140
Dublin 128
Hong Kong 128
Warsaw 105
San Jose 86
Houston 74
Woodbridge 74
Seattle 67
Cambridge 62
Beijing 58
Wilmington 58
Seoul 55
Florence 49
Dong Ket 40
Ann Arbor 36
Milan 32
Mumbai 30
The Dalles 30
Princeton 29
Council Bluffs 28
Los Angeles 28
Ho Chi Minh City 25
Altamura 23
Lawrence 23
Clifton 22
Shanghai 21
Lauterbourg 20
New York 20
Hanoi 18
Barcelona 17
Rome 17
Boston 15
Helsinki 15
Buffalo 14
Moscow 14
Munich 14
Dallas 12
Hefei 12
Falls Church 11
Jakarta 11
Medford 11
Tokyo 11
Paris 10
San Diego 10
Gavirate 9
Melbourne 9
Cagliari 8
Guangzhou 8
Kent 8
Boardman 7
Chennai 7
Orem 7
Jacksonville 6
London 6
Redondo Beach 6
Basingstoke 5
Bologna 5
Brooklyn 5
Da Nang 5
Parma 5
San Francisco 5
Shenzhen 5
Brussels 4
Chicago 4
City of London 4
Dakar 4
Jinan 4
Tianjin 4
Toronto 4
Abidjan 3
Atlanta 3
Can Tho 3
Curitiba 3
Denver 3
Haiphong 3
Naples 3
Norwalk 3
Pontassieve 3
Pune 3
Querétaro 3
Reggio Emilia 3
Stockholm 3
São Paulo 3
Thái Nguyên 3
Amman 2
Amsterdam 2
Ankara 2
Baku 2
Biên Hòa 2
Brampton 2
Buenos Aires 2
Camerino 2
Casablanca 2
Ferrara 2
Genoa 2
Gustavo Adolfo Madero 2
Totale 3.087
Nome #
The 1,2,4-Triazolo[4,3-a]pyrazin-3-one as a Versatile Scaffold for the Design of Potent Adenosine Human Receptor Antagonists. Structural Investigations to Target the A2A Receptor Subtype 274
Design and synthesis of new adenosine receptor antagonists as neuroprotective agents 255
The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3-d]pyrimidine core in affecting adenosine A1 and A2A receptor affinity and selectivity profiles 227
3-Hydroxy-1H-quinazoline-2,4-dione as a New Scaffold to Develop Potent and Selective Inhibitors of the Tumor-Associated Carbonic Anhydrases IX and XII 227
Structural investigations on coumarins leading to chromeno[4,3-c]pyrazol-4-ones and pyrano[4,3-c]pyrazol-4-ones: New scaffolds for the design of the tumor-associated carbonic anhydrase isoforms IX and XII 226
Imidazo[1,2-a]pyrazin-8-amine core for the design of new adenosine receptor antagonists: Structural exploration to target the A3 and A2A subtypes 215
Design, synthesis, and pharmacological characterization of 2‑(2- furanyl)thiazolo[5,4‑d]pyrimidine-5,7-diamine derivatives: new highly potent A2A adenosine receptor inverse agonists with antinociceptive activity 204
Modifications on the Amino-3,5-dicyanopyridine Core To Obtain Multifaceted Adenosine Receptor Ligands with Antineuropathic Activity 203
Antioxidant-Conjugated 1,2,4-Triazolo[4,3-a]pyrazin-3-one Derivatives: Highly Potent and Selective Human A2A Adenosine Receptor Antagonists Possessing Protective Efficacy in Neuropathic Pain 199
Development of novel pyridazinone-based adenosine receptor ligands 189
Exploring the 2- and 5-positions of the pyrazolo[4,3-d]pyrimidin-7-amino scaffold to target human A1 and A2A adenosine receptors 188
New 8-amino-1,2,4-triazolo[4,3-a]pyrazin-3-one derivatives. Evaluation of different moieties on the 6-aryl ring to obtain potent and selective human A2A adenosine receptor antagonists 187
The aminopyridine-3,5-dicarbonitrile core for the design of new non-nucleoside-like agonists of the human adenosine A2Breceptor 178
Aminopyridine-3,5-carbonitrile core for the design of new adenosine receptor agonists: structural exploration to target the A1 subtype 171
Novel human adenosine receptor antagonists based on the 7-amino-thiazolo[5,4-d]pyrimidine scaffold. Structural investigations at the 2-, 5- and 7-positions to enhance affinity and tune selectivity 170
2-Aryl-1,2,4-triazolo[4,3-a]pyrazin-3-one derivatives as new potent adenosine human A2A receptor antagonists 169
Novel 8-amino-1,2,4-triazolo[4,3-a]pyrazin-3-one derivatives as potent human adenosine A 1 and A 2A receptor antagonists. Evaluation of their protective effect against β-amyloid-induced neurotoxicity in SH-SY5Y cells 168
3-Hydroxy-1H-quinazoline-2,4-dione derivatives as new potent and selective inhibitors of the tumor-associated carbonic anhydrase IX and XII. 168
Structural refinement of pyrazolo[4,3-d]pyrimidine derivatives to obtain highly potent and selective antagonists for the human A3 adenosine receptor 159
Identification of novel thiazolo[5,4-d]pyrimidine derivatives as human A1and A2Aadenosine receptor antagonists/inverse agonists 141
Structure-activity relationship studies and pharmacological characterization of N5-heteroarylalkyl-substituted-2-(2-furanyl)thiazolo[5,4-d]pyrimidine-5,7-diamine-based derivatives as inverse agonists at human A2Aadenosine receptor 138
New 5-heteroaryl-pyrazolo[4,3-d]pyrimidin-7-amines as dual human adenosine A1 and A2A receptor antagonists. 137
Thiazolo[5,4-d]pyrimidin-7-amino derivatives as dual human adenosine A2A/A1 receptor antagonists. 132
New aminopyridine-3,5-dicarbonitirles as adenosine A2B receptor non-nucleoside agonists. 130
Crystal Structure and Subsequent Ligand Design of a Nonriboside Partial Agonist Bound to the Adenosine A2A Receptor 91
Totale 4.546
Categoria #
all - tutte 12.594
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.594


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022185 6 12 27 4 6 8 7 13 6 17 30 49
2022/2023522 43 90 45 30 36 96 62 44 56 0 15 5
2023/2024219 5 20 23 10 7 53 9 48 10 18 10 6
2024/20251.347 30 151 71 152 440 213 14 86 62 40 53 35
2025/20261.429 175 177 64 130 163 61 175 70 103 101 51 159
2026/20276 6 0 0 0 0 0 0 0 0 0 0 0
Totale 4.546